nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—CYP2C9—brain cancer	0.627	1	CbGaD
Medroxyprogesterone Acetate—CYP3A4—Temozolomide—brain cancer	0.033	0.39	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Lomustine—brain cancer	0.0281	0.332	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Etoposide—brain cancer	0.0167	0.198	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Etoposide—brain cancer	0.00679	0.0802	CbGbCtD
Medroxyprogesterone Acetate—AKR1C3—Podofilox—Etoposide—brain cancer	0.00394	1	CbGdCrCtD
Medroxyprogesterone Acetate—HSD3B2—gonad—brain cancer	0.00269	0.052	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—pituitary gland—brain cancer	0.00263	0.0507	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—endocrine gland—brain cancer	0.00204	0.0393	CbGeAlD
Medroxyprogesterone Acetate—SHBG—hindbrain—brain cancer	0.00201	0.0389	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—head—brain cancer	0.00201	0.0388	CbGeAlD
Medroxyprogesterone Acetate—PGR—blood vessel—brain cancer	0.0019	0.0367	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—central nervous system—brain cancer	0.00183	0.0354	CbGeAlD
Medroxyprogesterone Acetate—PGR—hindbrain—brain cancer	0.00181	0.035	CbGeAlD
Medroxyprogesterone Acetate—ESR1—blood vessel—brain cancer	0.00149	0.0287	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—brain—brain cancer	0.00146	0.0281	CbGeAlD
Medroxyprogesterone Acetate—ESR1—hindbrain—brain cancer	0.00142	0.0274	CbGeAlD
Medroxyprogesterone Acetate—SHBG—brainstem—brain cancer	0.00115	0.0223	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—pituitary gland—brain cancer	0.00111	0.0214	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—medulla oblongata—brain cancer	0.00107	0.0207	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—hindbrain—brain cancer	0.00105	0.0202	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—midbrain—brain cancer	0.000978	0.0189	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—spinal cord—brain cancer	0.000954	0.0184	CbGeAlD
Medroxyprogesterone Acetate—SHBG—gonad—brain cancer	0.000854	0.0165	CbGeAlD
Medroxyprogesterone Acetate—SHBG—pituitary gland—brain cancer	0.000833	0.0161	CbGeAlD
Medroxyprogesterone Acetate—ESR1—brainstem—brain cancer	0.000813	0.0157	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—cerebellum—brain cancer	0.000756	0.0146	CbGeAlD
Medroxyprogesterone Acetate—PGR—pituitary gland—brain cancer	0.000751	0.0145	CbGeAlD
Medroxyprogesterone Acetate—AR—telencephalon—brain cancer	0.000735	0.0142	CbGeAlD
Medroxyprogesterone Acetate—ESR1—telencephalon—brain cancer	0.000721	0.0139	CbGeAlD
Medroxyprogesterone Acetate—SHBG—endocrine gland—brain cancer	0.000646	0.0125	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—brain—brain cancer	0.000614	0.0119	CbGeAlD
Medroxyprogesterone Acetate—AR—gonad—brain cancer	0.000613	0.0118	CbGeAlD
Medroxyprogesterone Acetate—ESR1—gonad—brain cancer	0.000602	0.0116	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—brainstem—brain cancer	0.000599	0.0116	CbGeAlD
Medroxyprogesterone Acetate—AR—pituitary gland—brain cancer	0.000598	0.0115	CbGeAlD
Medroxyprogesterone Acetate—ESR1—pituitary gland—brain cancer	0.000587	0.0113	CbGeAlD
Medroxyprogesterone Acetate—SHBG—central nervous system—brain cancer	0.000582	0.0112	CbGeAlD
Medroxyprogesterone Acetate—PGR—endocrine gland—brain cancer	0.000582	0.0112	CbGeAlD
Medroxyprogesterone Acetate—PGR—head—brain cancer	0.000574	0.0111	CbGeAlD
Medroxyprogesterone Acetate—SHBG—cerebellum—brain cancer	0.000569	0.011	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—telencephalon—brain cancer	0.000532	0.0103	CbGeAlD
Medroxyprogesterone Acetate—PGR—central nervous system—brain cancer	0.000524	0.0101	CbGeAlD
Medroxyprogesterone Acetate—AR—spinal cord—brain cancer	0.000515	0.00994	CbGeAlD
Medroxyprogesterone Acetate—PGR—cerebellum—brain cancer	0.000512	0.00989	CbGeAlD
Medroxyprogesterone Acetate—CYP2C8—pituitary gland—brain cancer	0.000484	0.00934	CbGeAlD
Medroxyprogesterone Acetate—AR—endocrine gland—brain cancer	0.000463	0.00895	CbGeAlD
Medroxyprogesterone Acetate—SHBG—brain—brain cancer	0.000462	0.00892	CbGeAlD
Medroxyprogesterone Acetate—AR—head—brain cancer	0.000457	0.00883	CbGeAlD
Medroxyprogesterone Acetate—ESR1—endocrine gland—brain cancer	0.000455	0.00878	CbGeAlD
Medroxyprogesterone Acetate—ESR1—head—brain cancer	0.000449	0.00867	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—gonad—brain cancer	0.000444	0.00857	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—pituitary gland—brain cancer	0.000433	0.00836	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—medulla oblongata—brain cancer	0.000418	0.00807	CbGeAlD
Medroxyprogesterone Acetate—AR—central nervous system—brain cancer	0.000418	0.00806	CbGeAlD
Medroxyprogesterone Acetate—PGR—brain—brain cancer	0.000416	0.00803	CbGeAlD
Medroxyprogesterone Acetate—ESR1—central nervous system—brain cancer	0.00041	0.00791	CbGeAlD
Medroxyprogesterone Acetate—ESR1—cerebellum—brain cancer	0.000401	0.00774	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—midbrain—brain cancer	0.000382	0.00738	CbGeAlD
Medroxyprogesterone Acetate—CYP2C8—endocrine gland—brain cancer	0.000375	0.00724	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—spinal cord—brain cancer	0.000373	0.0072	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—endocrine gland—brain cancer	0.000336	0.00648	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—endocrine gland—brain cancer	0.000333	0.00643	CbGeAlD
Medroxyprogesterone Acetate—AR—brain—brain cancer	0.000331	0.0064	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—head—brain cancer	0.000331	0.0064	CbGeAlD
Medroxyprogesterone Acetate—ESR1—brain—brain cancer	0.000325	0.00628	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—central nervous system—brain cancer	0.000302	0.00584	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—cerebellum—brain cancer	0.000296	0.00571	CbGeAlD
Medroxyprogesterone Acetate—Stomatitis—Carmustine—brain cancer	0.00029	0.00166	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract infection—Carmustine—brain cancer	0.000289	0.00166	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Procarbazine—brain cancer	0.000289	0.00166	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Hydroxyurea—brain cancer	0.000287	0.00165	CcSEcCtD
Medroxyprogesterone Acetate—Infestation—Temozolomide—brain cancer	0.000287	0.00165	CcSEcCtD
Medroxyprogesterone Acetate—Infestation NOS—Temozolomide—brain cancer	0.000287	0.00165	CcSEcCtD
Medroxyprogesterone Acetate—Depression—Temozolomide—brain cancer	0.000286	0.00164	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Lomustine—brain cancer	0.000283	0.00163	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Procarbazine—brain cancer	0.000283	0.00162	CcSEcCtD
Medroxyprogesterone Acetate—Neuropathy peripheral—Temozolomide—brain cancer	0.000281	0.00161	CcSEcCtD
Medroxyprogesterone Acetate—Stomatitis—Temozolomide—brain cancer	0.00028	0.00161	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract infection—Temozolomide—brain cancer	0.000279	0.0016	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000276	0.00158	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Procarbazine—brain cancer	0.000274	0.00157	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Procarbazine—brain cancer	0.000272	0.00156	CcSEcCtD
Medroxyprogesterone Acetate—Hepatobiliary disease—Temozolomide—brain cancer	0.000272	0.00156	CcSEcCtD
Medroxyprogesterone Acetate—Sinusitis—Temozolomide—brain cancer	0.000269	0.00155	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Procarbazine—brain cancer	0.000269	0.00154	CcSEcCtD
Medroxyprogesterone Acetate—Cramp muscle—Etoposide—brain cancer	0.000268	0.00154	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Carmustine—brain cancer	0.000268	0.00154	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—brain—brain cancer	0.000268	0.00518	CbGeAlD
Medroxyprogesterone Acetate—Haemorrhage—Carmustine—brain cancer	0.000267	0.00153	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Hydroxyurea—brain cancer	0.000266	0.00153	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Hydroxyurea—brain cancer	0.000265	0.00152	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Procarbazine—brain cancer	0.000263	0.00151	CcSEcCtD
Medroxyprogesterone Acetate—Alanine aminotransferase increased—Etoposide—brain cancer	0.000263	0.00151	CcSEcCtD
Medroxyprogesterone Acetate—Oedema peripheral—Carmustine—brain cancer	0.000263	0.00151	CcSEcCtD
Medroxyprogesterone Acetate—Connective tissue disorder—Carmustine—brain cancer	0.000262	0.0015	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Procarbazine—brain cancer	0.000261	0.0015	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Temozolomide—brain cancer	0.000259	0.00149	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Hydroxyurea—brain cancer	0.000259	0.00149	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Procarbazine—brain cancer	0.000259	0.00149	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Temozolomide—brain cancer	0.000258	0.00148	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Temozolomide—brain cancer	0.000258	0.00148	CcSEcCtD
Medroxyprogesterone Acetate—Dysphagia—Etoposide—brain cancer	0.000258	0.00148	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Carmustine—brain cancer	0.000257	0.00147	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Temozolomide—brain cancer	0.000256	0.00147	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Temozolomide—brain cancer	0.000255	0.00146	CcSEcCtD
Medroxyprogesterone Acetate—Oedema peripheral—Temozolomide—brain cancer	0.000254	0.00146	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—endocrine gland—brain cancer	0.000254	0.0049	CbGeAlD
Medroxyprogesterone Acetate—Bronchospasm—Etoposide—brain cancer	0.000253	0.00145	CcSEcCtD
Medroxyprogesterone Acetate—Connective tissue disorder—Temozolomide—brain cancer	0.000253	0.00145	CcSEcCtD
Medroxyprogesterone Acetate—Urethral disorder—Temozolomide—brain cancer	0.000253	0.00145	CcSEcCtD
Medroxyprogesterone Acetate—Sweating increased—Etoposide—brain cancer	0.000251	0.00144	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Procarbazine—brain cancer	0.00025	0.00143	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Carmustine—brain cancer	0.000249	0.00143	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Hydroxyurea—brain cancer	0.000249	0.00143	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Temozolomide—brain cancer	0.000248	0.00142	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Procarbazine—brain cancer	0.000248	0.00142	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Temozolomide—brain cancer	0.000244	0.0014	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000243	0.00139	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Hydroxyurea—brain cancer	0.000242	0.00139	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Temozolomide—brain cancer	0.000241	0.00138	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Procarbazine—brain cancer	0.000241	0.00138	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Temozolomide—brain cancer	0.00024	0.00138	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—brain—brain cancer	0.00024	0.00464	CbGeAlD
Medroxyprogesterone Acetate—Body temperature increased—Procarbazine—brain cancer	0.000239	0.00137	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Procarbazine—brain cancer	0.000239	0.00137	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Temozolomide—brain cancer	0.000239	0.00137	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Carmustine—brain cancer	0.000236	0.00135	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Hydroxyurea—brain cancer	0.000234	0.00134	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Temozolomide—brain cancer	0.000234	0.00134	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Carmustine—brain cancer	0.000234	0.00134	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Hydroxyurea—brain cancer	0.000233	0.00134	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Temozolomide—brain cancer	0.000233	0.00134	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Temozolomide—brain cancer	0.000232	0.00133	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Carmustine—brain cancer	0.000232	0.00133	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Carmustine—brain cancer	0.000232	0.00133	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Temozolomide—brain cancer	0.000231	0.00133	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Hydroxyurea—brain cancer	0.00023	0.00132	CcSEcCtD
Medroxyprogesterone Acetate—Infestation NOS—Etoposide—brain cancer	0.00023	0.00132	CcSEcCtD
Medroxyprogesterone Acetate—Infestation—Etoposide—brain cancer	0.00023	0.00132	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Hydroxyurea—brain cancer	0.00023	0.00132	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—central nervous system—brain cancer	0.000229	0.00442	CbGeAlD
Medroxyprogesterone Acetate—Alopecia—Temozolomide—brain cancer	0.000228	0.00131	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Hydroxyurea—brain cancer	0.000228	0.00131	CcSEcCtD
Medroxyprogesterone Acetate—Acute coronary syndrome—Etoposide—brain cancer	0.000226	0.0013	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Temozolomide—brain cancer	0.000226	0.0013	CcSEcCtD
Medroxyprogesterone Acetate—Neuropathy peripheral—Etoposide—brain cancer	0.000225	0.00129	CcSEcCtD
Medroxyprogesterone Acetate—Myocardial infarction—Etoposide—brain cancer	0.000225	0.00129	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Carmustine—brain cancer	0.000225	0.00129	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Temozolomide—brain cancer	0.000224	0.00129	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Temozolomide—brain cancer	0.000224	0.00129	CcSEcCtD
Medroxyprogesterone Acetate—Stomatitis—Etoposide—brain cancer	0.000224	0.00128	CcSEcCtD
Medroxyprogesterone Acetate—Jaundice—Etoposide—brain cancer	0.000224	0.00128	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Hydroxyurea—brain cancer	0.000223	0.00128	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Procarbazine—brain cancer	0.000223	0.00128	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Temozolomide—brain cancer	0.00022	0.00126	CcSEcCtD
Medroxyprogesterone Acetate—Tremor—Carmustine—brain cancer	0.000218	0.00125	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Procarbazine—brain cancer	0.000217	0.00125	CcSEcCtD
Medroxyprogesterone Acetate—Hepatobiliary disease—Etoposide—brain cancer	0.000217	0.00125	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Temozolomide—brain cancer	0.000217	0.00125	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Carmustine—brain cancer	0.000215	0.00123	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Procarbazine—brain cancer	0.000214	0.00123	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Carmustine—brain cancer	0.000213	0.00122	CcSEcCtD
Medroxyprogesterone Acetate—Tremor—Temozolomide—brain cancer	0.00021	0.00121	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Hydroxyurea—brain cancer	0.000209	0.0012	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Hydroxyurea—brain cancer	0.000208	0.0012	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Temozolomide—brain cancer	0.000208	0.00119	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Temozolomide—brain cancer	0.000207	0.00119	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Procarbazine—brain cancer	0.000207	0.00119	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Hydroxyurea—brain cancer	0.000206	0.00118	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Temozolomide—brain cancer	0.000206	0.00118	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Temozolomide—brain cancer	0.000205	0.00118	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Hydroxyurea—brain cancer	0.000204	0.00117	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Etoposide—brain cancer	0.000204	0.00117	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000202	0.00116	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Temozolomide—brain cancer	0.000202	0.00116	CcSEcCtD
Medroxyprogesterone Acetate—Urethral disorder—Etoposide—brain cancer	0.000202	0.00116	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Hydroxyurea—brain cancer	0.000202	0.00116	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Temozolomide—brain cancer	0.000202	0.00116	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Carmustine—brain cancer	0.000201	0.00115	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Hydroxyurea—brain cancer	0.0002	0.00115	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Procarbazine—brain cancer	0.0002	0.00115	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Temozolomide—brain cancer	0.000198	0.00114	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Carmustine—brain cancer	0.000198	0.00113	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Carmustine—brain cancer	0.000198	0.00113	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Carmustine—brain cancer	0.000197	0.00113	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Etoposide—brain cancer	0.000195	0.00112	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Temozolomide—brain cancer	0.000194	0.00112	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Hydroxyurea—brain cancer	0.000193	0.00111	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Etoposide—brain cancer	0.000193	0.00111	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Procarbazine—brain cancer	0.000193	0.0011	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Etoposide—brain cancer	0.000191	0.0011	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Carmustine—brain cancer	0.000191	0.0011	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Temozolomide—brain cancer	0.000191	0.0011	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Temozolomide—brain cancer	0.000191	0.0011	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Procarbazine—brain cancer	0.000191	0.0011	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Procarbazine—brain cancer	0.000191	0.00109	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Temozolomide—brain cancer	0.00019	0.00109	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Procarbazine—brain cancer	0.00019	0.00109	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00019	0.00109	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Carmustine—brain cancer	0.000189	0.00109	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Temozolomide—brain cancer	0.000189	0.00108	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Carmustine—brain cancer	0.000188	0.00108	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Etoposide—brain cancer	0.000187	0.00107	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Temozolomide—brain cancer	0.000187	0.00107	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Etoposide—brain cancer	0.000186	0.00107	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Etoposide—brain cancer	0.000186	0.00107	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Carmustine—brain cancer	0.000186	0.00106	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Hydroxyurea—brain cancer	0.000185	0.00106	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Etoposide—brain cancer	0.000185	0.00106	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Carmustine—brain cancer	0.000185	0.00106	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Temozolomide—brain cancer	0.000185	0.00106	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Temozolomide—brain cancer	0.000183	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Temozolomide—brain cancer	0.000183	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Etoposide—brain cancer	0.000182	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Temozolomide—brain cancer	0.000182	0.00104	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Carmustine—brain cancer	0.000181	0.00104	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Procarbazine—brain cancer	0.00018	0.00103	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Temozolomide—brain cancer	0.00018	0.00103	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Temozolomide—brain cancer	0.000179	0.00103	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Temozolomide—brain cancer	0.000178	0.00102	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Carmustine—brain cancer	0.000177	0.00102	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Temozolomide—brain cancer	0.000177	0.00102	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Etoposide—brain cancer	0.000176	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Temozolomide—brain cancer	0.000175	0.001	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Etoposide—brain cancer	0.000174	0.000996	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Hydroxyurea—brain cancer	0.000173	0.000991	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Carmustine—brain cancer	0.000173	0.00099	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Etoposide—brain cancer	0.000173	0.00099	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Carmustine—brain cancer	0.000171	0.000983	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Carmustine—brain cancer	0.00017	0.000976	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Carmustine—brain cancer	0.000169	0.000969	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Carmustine—brain cancer	0.000168	0.000966	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Hydroxyurea—brain cancer	0.000168	0.000965	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000167	0.000957	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Etoposide—brain cancer	0.000167	0.000956	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Etoposide—brain cancer	0.000166	0.000952	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Temozolomide—brain cancer	0.000166	0.00095	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Carmustine—brain cancer	0.000165	0.000945	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Temozolomide—brain cancer	0.000164	0.000943	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Carmustine—brain cancer	0.000164	0.000938	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Temozolomide—brain cancer	0.000163	0.000937	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Temozolomide—brain cancer	0.000163	0.000934	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Carmustine—brain cancer	0.000162	0.00093	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Etoposide—brain cancer	0.000162	0.000929	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Etoposide—brain cancer	0.000161	0.000925	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Temozolomide—brain cancer	0.000161	0.000925	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Hydroxyurea—brain cancer	0.00016	0.00092	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Temozolomide—brain cancer	0.000159	0.000913	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Temozolomide—brain cancer	0.000158	0.000907	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Temozolomide—brain cancer	0.000158	0.000906	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Etoposide—brain cancer	0.000158	0.000905	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Temozolomide—brain cancer	0.000157	0.000898	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Carmustine—brain cancer	0.000156	0.000896	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Etoposide—brain cancer	0.000156	0.000892	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Hydroxyurea—brain cancer	0.000155	0.000889	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Carmustine—brain cancer	0.000155	0.000889	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Etoposide—brain cancer	0.000153	0.000877	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000152	0.000871	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Etoposide—brain cancer	0.000151	0.000866	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Temozolomide—brain cancer	0.000151	0.000866	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Carmustine—brain cancer	0.00015	0.000859	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Carmustine—brain cancer	0.00015	0.000859	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Temozolomide—brain cancer	0.00015	0.000859	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Hydroxyurea—brain cancer	0.000149	0.000855	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Hydroxyurea—brain cancer	0.000148	0.000848	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Etoposide—brain cancer	0.000148	0.000848	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Hydroxyurea—brain cancer	0.000148	0.000847	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Hydroxyurea—brain cancer	0.000147	0.000842	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Etoposide—brain cancer	0.000147	0.000841	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Etoposide—brain cancer	0.000146	0.000835	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Temozolomide—brain cancer	0.000145	0.000835	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Temozolomide—brain cancer	0.000145	0.00083	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Temozolomide—brain cancer	0.000145	0.00083	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Etoposide—brain cancer	0.000143	0.000823	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Etoposide—brain cancer	0.000143	0.00082	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Etoposide—brain cancer	0.000142	0.000816	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Etoposide—brain cancer	0.000142	0.000813	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Etoposide—brain cancer	0.00014	0.000801	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Carmustine—brain cancer	0.00014	0.000801	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Hydroxyurea—brain cancer	0.000139	0.000799	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Etoposide—brain cancer	0.000137	0.000785	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Carmustine—brain cancer	0.000136	0.00078	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Temozolomide—brain cancer	0.000135	0.000774	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Etoposide—brain cancer	0.000132	0.000755	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Temozolomide—brain cancer	0.000131	0.000754	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Etoposide—brain cancer	0.000131	0.000749	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Etoposide—brain cancer	0.00013	0.000747	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Carmustine—brain cancer	0.00013	0.000744	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Temozolomide—brain cancer	0.00013	0.000743	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Etoposide—brain cancer	0.000127	0.000731	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Etoposide—brain cancer	0.000127	0.000726	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Etoposide—brain cancer	0.000126	0.000725	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Carmustine—brain cancer	0.000125	0.000719	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Etoposide—brain cancer	0.000125	0.000719	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Temozolomide—brain cancer	0.000125	0.000719	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Temozolomide—brain cancer	0.000121	0.000695	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Etoposide—brain cancer	0.000121	0.000693	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Carmustine—brain cancer	0.00012	0.000691	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Etoposide—brain cancer	0.00012	0.000687	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Carmustine—brain cancer	0.000119	0.000685	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Carmustine—brain cancer	0.000119	0.000685	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Carmustine—brain cancer	0.000119	0.000681	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Temozolomide—brain cancer	0.000116	0.000668	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Etoposide—brain cancer	0.000116	0.000668	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Etoposide—brain cancer	0.000116	0.000664	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Etoposide—brain cancer	0.000116	0.000664	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Temozolomide—brain cancer	0.000115	0.000662	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Temozolomide—brain cancer	0.000115	0.000662	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Temozolomide—brain cancer	0.000115	0.000658	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Carmustine—brain cancer	0.000113	0.000646	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Temozolomide—brain cancer	0.000109	0.000624	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Etoposide—brain cancer	0.000108	0.000619	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Etoposide—brain cancer	0.000105	0.000603	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Etoposide—brain cancer	0.000104	0.000595	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—HES1—brain cancer	0.000104	0.00177	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—CCND1—brain cancer	0.000103	0.00177	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—PDGFRA—brain cancer	0.000102	0.00175	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—IL2—brain cancer	0.000102	0.00175	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—CCND1—brain cancer	0.000101	0.00173	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Endoderm Differentiation—CTNNB1—brain cancer	0.000101	0.00173	CbGpPWpGaD
Medroxyprogesterone Acetate—Diarrhoea—Etoposide—brain cancer	0.0001	0.000575	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—IRS2—brain cancer	0.0001	0.00171	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—CTNNB1—brain cancer	0.0001	0.00171	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CYP2C9—brain cancer	0.0001	0.00171	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—RELA—brain cancer	9.99e-05	0.00171	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—CCND1—brain cancer	9.95e-05	0.0017	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—CTNNB1—brain cancer	9.86e-05	0.00169	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—LKB1 signaling events—TP53—brain cancer	9.83e-05	0.00168	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—DTX2—brain cancer	9.76e-05	0.00167	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—ESR2—brain cancer	9.74e-05	0.00167	CbGpPWpGaD
Medroxyprogesterone Acetate—Dizziness—Etoposide—brain cancer	9.69e-05	0.000556	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—CCND1—brain cancer	9.56e-05	0.00164	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—brain cancer	9.46e-05	0.00162	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	9.45e-05	0.00162	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PTCH2—brain cancer	9.38e-05	0.00161	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	9.36e-05	0.0016	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—STAT3—brain cancer	9.34e-05	0.0016	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Etoposide—brain cancer	9.32e-05	0.000534	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	9.27e-05	0.00159	CbGpPWpGaD
Medroxyprogesterone Acetate—Rash—Etoposide—brain cancer	9.24e-05	0.00053	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Etoposide—brain cancer	9.23e-05	0.00053	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—NOTCH2—brain cancer	9.23e-05	0.00158	CbGpPWpGaD
Medroxyprogesterone Acetate—Headache—Etoposide—brain cancer	9.18e-05	0.000527	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	9.15e-05	0.00157	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	9.1e-05	0.00156	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HES5—brain cancer	9.08e-05	0.00155	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—IL2—brain cancer	9e-05	0.00154	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—IRS2—brain cancer	8.97e-05	0.00154	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—CYP2C9—brain cancer	8.82e-05	0.00151	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—STRADA—brain cancer	8.82e-05	0.00151	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—IDH1—brain cancer	8.73e-05	0.00149	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Validated nuclear estrogen receptor alpha network—MYC—brain cancer	8.71e-05	0.00149	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Etoposide—brain cancer	8.7e-05	0.000499	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	8.7e-05	0.00149	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—APC—brain cancer	8.57e-05	0.00147	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	8.51e-05	0.00146	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—BSG—brain cancer	8.5e-05	0.00146	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—EGFR—brain cancer	8.49e-05	0.00145	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—CDK4—brain cancer	8.46e-05	0.00145	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—MYC—brain cancer	8.3e-05	0.00142	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—HEY1—brain cancer	8.27e-05	0.00142	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—STAT3—brain cancer	8.25e-05	0.00141	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—DLL1—brain cancer	8.11e-05	0.00139	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—EGFR—brain cancer	8.11e-05	0.00139	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	8.11e-05	0.00139	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—MYC—brain cancer	8.11e-05	0.00139	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—MYC—brain cancer	7.98e-05	0.00137	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—ESR2—brain cancer	7.42e-05	0.00127	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PTCH2—brain cancer	7.4e-05	0.00127	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—ABR—brain cancer	7.36e-05	0.00126	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—IDH1—brain cancer	7.31e-05	0.00125	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—EGFR—brain cancer	7.26e-05	0.00124	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	7.21e-05	0.00123	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HES5—brain cancer	7.17e-05	0.00123	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—GLI2—brain cancer	7.11e-05	0.00122	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	7.1e-05	0.00122	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—CCND1—brain cancer	7.09e-05	0.00121	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—NOTCH2—brain cancer	7.03e-05	0.0012	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	7.02e-05	0.0012	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	7.01e-05	0.0012	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—STRADA—brain cancer	6.96e-05	0.00119	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—SHH—brain cancer	6.9e-05	0.00118	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—ENO2—brain cancer	6.9e-05	0.00118	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—CTNNB1—brain cancer	6.84e-05	0.00117	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—OR14C36—brain cancer	6.74e-05	0.00115	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—OR4C12—brain cancer	6.74e-05	0.00115	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—GLI1—brain cancer	6.68e-05	0.00114	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—TP53—brain cancer	6.66e-05	0.00114	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	6.65e-05	0.00114	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	6.6e-05	0.00113	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—TP53—brain cancer	6.56e-05	0.00112	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SUFU—brain cancer	6.34e-05	0.00108	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.31e-05	0.00108	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	6.18e-05	0.00106	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—ERBB2—brain cancer	6.15e-05	0.00105	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—GFAP—brain cancer	6.11e-05	0.00105	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—VEGFA—brain cancer	6.02e-05	0.00103	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—CTNNB1—brain cancer	6.01e-05	0.00103	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.95e-05	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	5.88e-05	0.00101	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	5.82e-05	0.000996	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—ABR—brain cancer	5.81e-05	0.000994	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HEY1—brain cancer	5.79e-05	0.000992	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—ENO2—brain cancer	5.78e-05	0.000989	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—brain cancer	5.78e-05	0.000989	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—DTX2—brain cancer	5.73e-05	0.000981	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—ESR2—brain cancer	5.72e-05	0.000979	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—MYC—brain cancer	5.69e-05	0.000974	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—DLL1—brain cancer	5.68e-05	0.000973	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—ESR2—brain cancer	5.63e-05	0.000964	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—GLI2—brain cancer	5.61e-05	0.00096	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—EGFR—brain cancer	5.56e-05	0.000952	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—CCND1—brain cancer	5.46e-05	0.000935	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—NOTCH2—brain cancer	5.42e-05	0.000927	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	5.41e-05	0.000926	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PIK3CG—brain cancer	5.37e-05	0.000919	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—NOTCH2—brain cancer	5.33e-05	0.000913	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—GLI1—brain cancer	5.27e-05	0.000902	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—STAT3—brain cancer	5.24e-05	0.000896	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—DNMT1—brain cancer	5.22e-05	0.000894	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	5.19e-05	0.000889	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	5.12e-05	0.000877	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	5.12e-05	0.000877	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SUFU—brain cancer	5e-05	0.000855	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—VAV1—brain cancer	4.98e-05	0.000853	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SHH—brain cancer	4.83e-05	0.000827	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—GFAP—brain cancer	4.82e-05	0.000825	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	4.76e-05	0.000815	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	4.71e-05	0.000807	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—ESR2—brain cancer	4.69e-05	0.000803	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—TP53—brain cancer	4.67e-05	0.0008	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TRPC6—brain cancer	4.66e-05	0.000797	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.61e-05	0.00079	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	4.61e-05	0.000789	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PTCH1—brain cancer	4.58e-05	0.000784	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SMO—brain cancer	4.58e-05	0.000784	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HEY1—brain cancer	4.57e-05	0.000782	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—brain cancer	4.57e-05	0.000782	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	4.53e-05	0.000775	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	4.48e-05	0.000767	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—DLL1—brain cancer	4.48e-05	0.000767	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—NOTCH2—brain cancer	4.44e-05	0.00076	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—MYC—brain cancer	4.38e-05	0.00075	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PTCH2—brain cancer	4.34e-05	0.000743	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—HES1—brain cancer	4.29e-05	0.000734	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—EGFR—brain cancer	4.29e-05	0.000734	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—EGFR—brain cancer	4.26e-05	0.00073	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HES5—brain cancer	4.21e-05	0.00072	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—STRADA—brain cancer	4.08e-05	0.000699	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PDGFRA—brain cancer	4.08e-05	0.000699	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—DNMT1—brain cancer	3.98e-05	0.000681	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	3.95e-05	0.000676	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	3.87e-05	0.000663	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SHH—brain cancer	3.81e-05	0.000652	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—SIRT1—brain cancer	3.78e-05	0.000647	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.76e-05	0.000643	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TRPC6—brain cancer	3.68e-05	0.000629	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NOTCH2—brain cancer	3.66e-05	0.000627	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	3.63e-05	0.000622	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SMO—brain cancer	3.61e-05	0.000618	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PTCH1—brain cancer	3.61e-05	0.000618	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—TP53—brain cancer	3.6e-05	0.000616	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—IRS2—brain cancer	3.58e-05	0.000613	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—ESR2—brain cancer	3.57e-05	0.000612	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	3.55e-05	0.000608	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—VAV1—brain cancer	3.49e-05	0.000598	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ABR—brain cancer	3.41e-05	0.000583	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—NOTCH2—brain cancer	3.38e-05	0.000579	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GLI2—brain cancer	3.29e-05	0.000563	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—APC—brain cancer	3.17e-05	0.000542	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GLI1—brain cancer	3.09e-05	0.00053	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—MYC—brain cancer	3.07e-05	0.000526	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—DNMT1—brain cancer	3.07e-05	0.000525	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—DNMT1—brain cancer	3.02e-05	0.000517	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HES1—brain cancer	3e-05	0.000514	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.98e-05	0.00051	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SUFU—brain cancer	2.93e-05	0.000502	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NOTCH2—brain cancer	2.89e-05	0.000494	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—SIRT1—brain cancer	2.88e-05	0.000493	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PDGFRA—brain cancer	2.86e-05	0.000489	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GFAP—brain cancer	2.83e-05	0.000484	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP2C9—brain cancer	2.81e-05	0.000481	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SPP1—brain cancer	2.78e-05	0.000475	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—VAV1—brain cancer	2.75e-05	0.000471	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—ESR2—brain cancer	2.75e-05	0.000471	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—ESR2—brain cancer	2.71e-05	0.000464	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HEY1—brain cancer	2.68e-05	0.000459	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PIK3CG—brain cancer	2.65e-05	0.000454	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—DLL1—brain cancer	2.63e-05	0.00045	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—NOTCH2—brain cancer	2.61e-05	0.000446	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—NOTCH2—brain cancer	2.57e-05	0.00044	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IRS2—brain cancer	2.51e-05	0.00043	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—ERBB2—brain cancer	2.46e-05	0.000421	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—BSG—brain cancer	2.39e-05	0.000409	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HES1—brain cancer	2.37e-05	0.000405	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—MYC—brain cancer	2.34e-05	0.000401	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PDGFRA—brain cancer	2.25e-05	0.000386	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SHH—brain cancer	2.24e-05	0.000383	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—SIRT1—brain cancer	2.22e-05	0.000379	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—APC—brain cancer	2.22e-05	0.000379	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PIK3CG—brain cancer	2.22e-05	0.000379	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SPP1—brain cancer	2.19e-05	0.000375	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—SIRT1—brain cancer	2.18e-05	0.000374	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TRPC6—brain cancer	2.16e-05	0.000369	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CTNNB1—brain cancer	2.15e-05	0.000368	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SMO—brain cancer	2.12e-05	0.000363	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PTCH1—brain cancer	2.12e-05	0.000363	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—IDH1—brain cancer	2.06e-05	0.000352	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IRS2—brain cancer	1.98e-05	0.000339	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—BSG—brain cancer	1.95e-05	0.000333	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—STAT3—brain cancer	1.87e-05	0.000321	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—MYC—brain cancer	1.8e-05	0.000309	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—MYC—brain cancer	1.78e-05	0.000304	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—APC—brain cancer	1.75e-05	0.000299	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PIK3CG—brain cancer	1.75e-05	0.000299	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—MYC—brain cancer	1.74e-05	0.000298	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—RELA—brain cancer	1.73e-05	0.000296	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—ERBB2—brain cancer	1.72e-05	0.000295	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—EGFR—brain cancer	1.7e-05	0.000292	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NOTCH2—brain cancer	1.7e-05	0.00029	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.67e-05	0.000286	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—IDH1—brain cancer	1.67e-05	0.000286	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ENO2—brain cancer	1.62e-05	0.000278	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—VAV1—brain cancer	1.62e-05	0.000277	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL2—brain cancer	1.56e-05	0.000267	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CCND1—brain cancer	1.52e-05	0.00026	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP2C9—brain cancer	1.51e-05	0.000258	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CTNNB1—brain cancer	1.51e-05	0.000258	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—MYC—brain cancer	1.48e-05	0.000253	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HES1—brain cancer	1.39e-05	0.000238	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—RELA—brain cancer	1.37e-05	0.000234	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.36e-05	0.000233	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—ERBB2—brain cancer	1.36e-05	0.000232	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—VEGFA—brain cancer	1.33e-05	0.000227	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PDGFRA—brain cancer	1.32e-05	0.000227	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ENO2—brain cancer	1.32e-05	0.000226	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—STAT3—brain cancer	1.31e-05	0.000225	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SPP1—brain cancer	1.28e-05	0.00022	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—BSG—brain cancer	1.28e-05	0.00022	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL2—brain cancer	1.23e-05	0.000211	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MYC—brain cancer	1.22e-05	0.000209	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCND1—brain cancer	1.2e-05	0.000205	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—EGFR—brain cancer	1.19e-05	0.000204	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CTNNB1—brain cancer	1.19e-05	0.000203	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IRS2—brain cancer	1.16e-05	0.000199	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—MYC—brain cancer	1.13e-05	0.000193	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—IDH1—brain cancer	1.1e-05	0.000189	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—VEGFA—brain cancer	1.05e-05	0.000179	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—STAT3—brain cancer	1.04e-05	0.000177	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—APC—brain cancer	1.03e-05	0.000176	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PIK3CG—brain cancer	1.03e-05	0.000176	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TP53—brain cancer	1e-05	0.000171	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MYC—brain cancer	9.62e-06	0.000165	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—EGFR—brain cancer	9.41e-06	0.000161	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ENO2—brain cancer	8.72e-06	0.000149	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—MYC—brain cancer	8.68e-06	0.000149	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—MYC—brain cancer	8.55e-06	0.000146	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RELA—brain cancer	8.02e-06	0.000137	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ERBB2—brain cancer	7.97e-06	0.000136	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TP53—brain cancer	7.9e-06	0.000135	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PIK3CG—brain cancer	7.45e-06	0.000128	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL2—brain cancer	7.22e-06	0.000124	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCND1—brain cancer	7.04e-06	0.00012	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CTNNB1—brain cancer	6.97e-06	0.000119	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—VEGFA—brain cancer	6.14e-06	0.000105	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—STAT3—brain cancer	6.08e-06	0.000104	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PIK3CG—brain cancer	6.07e-06	0.000104	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MYC—brain cancer	5.65e-06	9.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EGFR—brain cancer	5.52e-06	9.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TP53—brain cancer	4.64e-06	7.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PIK3CG—brain cancer	4e-06	6.85e-05	CbGpPWpGaD
